Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/119184
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPrice, Z.en
dc.contributor.authorLokman, N.en
dc.contributor.authorRicciardelli, C.en
dc.date.issued2018en
dc.identifier.citationCancers, 2018; 10(12):482-1-482-21en
dc.identifier.issn2072-6694en
dc.identifier.issn2072-6694en
dc.identifier.urihttp://hdl.handle.net/2440/119184-
dc.description.abstractHyaluronan (HA), a glycosaminoglycan located in the extracellular matrix, is important in embryo development, inflammation, wound healing and cancer. There is an extensive body of research demonstrating the role of HA in all stages of cancer, from initiation to relapse and therapy resistance. HA interacts with multiple cell surface receptors, including CD44, receptor for hyaluronan mediated motility (RHAMM) and intracellular signaling pathways, including receptor tyrosine kinase pathways, to promote the survival and proliferation of cancer cells. Additionally, HA promotes the formation of cancer stem cell (CSC) populations, which are hypothesized to be responsible for the initiation of tumors and therapy resistance. Recent studies have identified that the molecular weight of HA plays differing roles on both normal and cancer cell behavior. This review explores the role of HA in cancer progression and therapy resistance and how its molecular weight is important in regulating CSC populations, epithelial to mesenchymal transition (EMT), ATP binding cassette (ABC) transporter expression and receptor tyrosine kinase pathways.en
dc.description.statementofresponsibilityZoe K. Price, Noor A. Lokman and Carmela Ricciardellien
dc.language.isoenen
dc.publisherMDPIen
dc.rights© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).en
dc.subjectHyaluronan; cancer; molecular weight; therapy resistance; cancer stem cells; oligosaccharides; tyrosine kinaseen
dc.titleDiffering roles of hyaluronan molecular weight on cancer cell behavior and chemotherapy resistanceen
dc.typeJournal articleen
dc.identifier.rmid0030105640en
dc.identifier.doi10.3390/cancers10120482en
dc.identifier.pubid452750-
pubs.library.collectionMedicine publicationsen
pubs.library.teamDS14en
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
dc.identifier.orcidPrice, Z. [0000-0001-5306-3468]en
dc.identifier.orcidRicciardelli, C. [0000-0001-7415-1854]en
Appears in Collections:Medicine publications

Files in This Item:
File Description SizeFormat 
hdl_119184.pdfPublished Version683.99 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.